ERMA was built by experienced Veeva users to solve real workflow challenges and drive meaningful change across life sciences industries.
Founded to transform MLR review processes, ERMA Systems has evolved into a leading platform for promotional content compliance, built by experienced Veeva users for life sciences teams worldwide.
Continuously pushing boundaries in regulatory technology to simplify what others make complex.
Maintaining the highest standards of regulatory adherence across every workflow we touch.
Dedicated to delivering measurable value for our clients from day one of implementation.
Building bridges between teams and departments reviews become seamless conversations.
Meet the experienced leaders driving ERMA's mission to transform regulatory workflows for life sciences companies
With extensive experience as a Brand Strategy and Account Lead, she has partnered with Fortune 500 companies across the U.S., EMEA, LATAM, and Canada. A seasoned Veeva user for over 15 years, Julia has a deep understanding of the challenges and inefficiencies that pharmaceutical companies face daily.
With over 15 years of experience in the tech industry, Ray began his career as a developer at MRM Worldwide, where he led teams to create interactive digital experiences for clients like Bristol-Myers Squibb (BMS) and WebMD.
Tyler consults with clients on best practices and strategic solutions, combining a deep understanding of digital platforms with research into evolving technology and regulatory landscapes. He manages cross-functional teams of developers, designers, and strategists—along with external vendors—to deliver complex digital initiatives from initial planning through launch.
Prior to founding PLK, Paul worked as an auditor at firms such as MNP LLP in Toronto, and Berdon LLP in New York City, before joining Brookfield Asset Management as a manager in their Corporate Finance department.
The ERMA team and its advisory board have the right skill set and experience to turn this into a successful story
Senior Manager, Medical Writing & Promotional Review at the PPD™ clinical research business of Thermo Fisher Scientific
Clinical Pharmacist with 20+ years in drug safety, pharmacovigilance, and medical writing. Senior Manager at Thermo Fisher Scientific.
Founder & Principal Kurins Consulting, LLC
Over three decades of Regulatory Affairs experience in a variety of Pharmaceutical and Biotech companies. Now providing consulting services for advertising and promotion for the pharmaceutical industry.
Director, Commercial Services, Acadia Pharmaceuticals, Inc.
Former lead of Marketing Operations at Zogenix, Recordati Rare Diseases, and Lundbeck.
Strategic Operations, Research and Product Development, CSL
Former Director, Emerging Technology Partnership and Innovation at Johnson & Johnson. Additionally, Associate Director, Technology Partnership and Business Development at Merck.
Associate Director of Commercial Operations, Recordati Rare Diseases
Associate Director of Commercial Operations at Recordati Rare Diseases with 10 years' experience, specializing in workflow software, regulatory environments, and marketing operations.
Sr. VP, Business Operations, Neurogene Inc.
Three decades of commercial experience. Former VP, of U.S. Commercial Operations for AveXis, the company that developed Zolgensma®, an FDA-approved treatment for spinal muscular atrophy; acquired by Novartis for $8.7 billion.
Real solutions for real MLR challenges
